Stock VM VOYAGEUR PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Market Closed - Toronto S.E.
Other stock markets
 03:37:32 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.065 CAD +18.18% Intraday chart for Voyageur Pharmaceuticals Ltd. +30.00% -13.33%
Apr. 26 Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
Mar. 26 Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America
AQ
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
AQ
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024
CI
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
AQ
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
AQ
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023
CI
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc
CI
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
AQ
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement
CI
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
AQ
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
AQ
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding
CI
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding
CI
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
AQ
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule
AQ
Voyageur Pharmaceuticals takes major step forward announcing international expansion
AQ
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance
CI
Voyageur Pharmaceuticals Initiates International Expansion
AQ
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
CI
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VM Stock
  4. News Voyageur Pharmaceuticals Ltd.